ANDREW HUBERMAN: What can you do in response to that
J Proteomics
While numerous studies have shown the benefits of semaglutide, we often see similar outcomes when patients achieve a healthy weight through other means, such as surgery. Further research into semaglutide and other hormone agonist medications is needed to determine which effects are independent of weight loss, advised Ali
While bupropion itself may contribute to weight loss as a secondary effect, which could theoretically complement the weight management goals of Saxenda, this potential benefit remains largely theoretical without robust UK-based clinical evidence
The dominant commercial carriers here are Blue Cross Blue Shield of Arizona, UnitedHealthcare, Aetna, Cigna, and Banner Health Plans, and the largest employers (Banner Health, Intel, Honeywell Aerospace, Raytheon, and Arizona State University) each handle GLP-1 coverage differently
Because retatrutide is not a licensed medicine in the UK, there is no validated, publicly available reconstitution protocol that individuals can safely follow outside of a clinical trial